Single Dose Radiotherapy Services Market to grow at 6.1% CAGR over the forecast period 2030.

Single-dose radiotherapy substitutes the requirement for extra hospital visits, with benefits for patient safety and well-being. Single-dose radiotherapy is delivered during or soon after surgery for breast cancer and is considered a viable alternative to conventional external beam radiotherapy.

Increasing technological advancements in radiotherapy procedure for the treatment of breast cancer and prostate cancer have led to the surging adoption of single-dose radiotherapies in clinical practice associated with improved outcomes. Single-dose radiotherapy is recognized as an extremely cost-effective treatment compared with other cancer treatments.

Increasing investments in the market, increasing number of research and development projects, and favorable regulatory policies are some factors enabling growth in the single dose radiotherapy services market. For example various government organizations such as American Cancer Society is investing in research and development programs for development of single dose radiotherapy. Recently the American cancer society have funded almost 162 research programs with around $67 million to encourage breast cancer research activities.

The COVID-19 pandemic has changed the national healthcare significances and expenditure however this is considered to be a short-term impact on the single-dose radiotherapy services market. The single-dose radiotherapy services market is expected to experience short-term negative growth owing to a sharp reduction in the number of single-dose radiotherapy services adoption rate in developed and emerging countries.

As a result of the continuing spread of COVID-19, various service providers are focusing on a novel approach to the treat pneumonia associated with COVID-19 using a single low dose of external beam radiation therapy which is known as Single Dose Radiation Therapy (SDRT). Previously various studies are reported regarding use of single small fraction of radiation to treat viral and bacterial pneumonia. Thus, scientists are believing that one small dose of radiotherapy can be effective for covid-19 treatment. This is providing an opportunity for single dose radiotherapy market to grow.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-13033

Key Takeaways from Single-Dose Radiotherapy Services Market Study

• Despite restricted growth amid COVID-19, the demand for single dose radiotherapy is expected to rise at nearly 5% in 2021
• As a result of increasing incidence of breast cancer, the U.S. will account for over 90% sales in North America
• Increasing focus on early diagnosis will enable the U.K. register 2.4% Y-o-Y growth in 2021
• Germany and France are expected to exhibit increasing demand to tackle concerns pertaining to rising incidence of cancer
• Increasing focus on research and development will drive growth in Japan and South Korea

 “Rising prevalence along with increasing awareness regarding breast and prostate cancer and the importance of early diagnosis, besides favorable reimbursement will offer lucrative growth opportunities for service providers in the long term,” says the FMI Analyst

Increase in Funding For Research Activities Offers Growth OpportunitiesLeading service providers in the single dose radiotherapy services market are strengthening their market position through collaboration with various government organization. Governments in various developed and developing countries are actively taking initiatives to encourage various research activities for the development of single-dose radiotherapy. For instance, In Brazil, government is taking initiative to create awareness regarding cancer treatment and research programs.

Pink October campaigns are arranged in Brazil by government, whose aim is to share facts about breast cancer, promoting awareness, providing countless access to diagnostic and therapeutic services, and funding to reduced mortality. One more example is the Blue November campaign, which works analogously to Pink October, however emphasize on prostate cancer.

Who is Winning?The global market is set to expand in the forecast period, due to the rising prevalence of breast cancer and prostate cancer globally and the adoption of single-dose radiotherapy. Leading organizations within the market are set to focus on research and development to offer early and precise diagnosis of the ailment, besides offering effective patient care.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-13033

Want more insights?Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2030. The global single-dose radiotherapy services market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the single-dose radiotherapy services market on basis of the main indication in detail, cover every aspect of the market such as (breast cancer and prostate cancer), therapy (External Beam Radiotherapy and Internal Beam Radiotherapy), and service provider (Hospitals, Radiotherapy Centers and Specialized cancer institute) across seven major regions.

Single Dose Radiotherapy Services Market by CategoryIndication

• Breast Cancer
• Prostate Cancer

Therapy

• External Beam Radiotherapy
• Internal Beam Radiotherapy

Service Provider

• Hospitals
• Radiotherapy Centers
• Specialized Cancer Institutes

Region

• North America
• Latin America
• Europe
• East Asia
• South Asia
• The Middle East and Africa (MEA)
• Oceania

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/13033